

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients.


Defence shares and lenders lead gains in Europe *


PM Keir Starmer vows to cut trade barriers with key partners *


(Alliance News) - The bloodbath in global equities worsened on Monday, in a roller-coaster end to the day, as Donald Trump warned China he would raise...


(Alliance News) - AstraZeneca PLC on Friday said it has received approval in the EU for two different treatments for breast and lung cancer.


(Alliance News) - London stocks are called down on Friday morning, as the UK government considers its response to US tariffs and the global market is ...


(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patien...